Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer

By Dent Susan  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 295-310

Springer Publishing Company

Access to resources Recommend Favorite

Impact of BMI on serum estradiol and bone turnover markers in postmenopausal women with hormone-sensitive early breast cancer treated with anastrozole

By Kyvernitakis I.   Knöll D.   Struck M.   Hars O.   Bauer T.   Hadji P.  

Journal of Cancer Research and Clinical Oncology, Vol. 140, Iss. 1, 2014-01 ,pp. : 159-166

Springer Publishing Company

Access to resources Recommend Favorite

Systematic review of aromatase inhibitors in the first-line treatment for hormone sensitive advanced or metastatic breast cancer

By Riemsma Rob  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 9-24

Springer Publishing Company

Access to resources Recommend Favorite

Exemestane: A Review of its Use as Adjuvant Treatment for Early Breast Cancer in Postmenopausal Women

By Moen Marit D.   Wagstaff Antona J.  

American Journal of Cancer, Vol. 5, Iss. 4, 2006-01 ,pp. : 259-272

Adis International

Access to resources Recommend Favorite

A Review of the Efficacy of Anastrozole in Postmenopausal Women with Advanced Breast Cancer with Visceral Metastases

By Howell A.  

Breast Cancer Research and Treatment, Vol. 82, Iss. 3, 2003-01 ,pp. : 215-222

Springer Publishing Company

Access to resources Recommend Favorite